Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis

被引：0
|
作者：
Spadaro, A. [1 ]
Scarno, A. [1 ]
Carboni, A. [1 ]
Perrotta, F. M. [1 ]
Catalano, C. [2 ]
Lubrano, E. [3 ]
Valesini, G. [1 ]
机构：
[1] Univ Roma La Sapienza, UOC Reumatol, Dipartimento Med Interna & Specialita Med, Rome, Italy
[2] Univ Roma La Sapienza, Radiol Cent UOC A, Dipartimento Med Mol, Rome, Italy
[3] Univ Molise, Dipartimento Med & Sci Salute, Campobasso, Italy
来源：
REUMATISMO | 2013年 / 65卷 / 03期
关键词：
Certolizumab pegol; Axial spondyloarthritis; Magnetic resonance;
D O I：
10.4081/reumatismo.2013.134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In axial spondyloarthritis (SpA), the efficacy of certolizumab pegol (CZP), a novel pegylated anti-tumor necrosis factor alpha drug has not been investigated. We report that CZP showed a rapid effectiveness, assessed clinically and by magnetic resonance imaging, in a patient with a non-radiographic axial SpA, classified according to Assessment in SpondyloArthritis International Society (ASAS) criteria. This case suggests that CZP could be considered an useful treatment in non-radiographic axial SpA, supporting that an earlier therapeutic approach could play a relevant role in the management of the disease.
引用
收藏
页码：134 / 137
页数：4
相关论文
共 50 条
  • [41] Etanercept for the treatment of non-radiographic axial spondyloarthritis
    Rodriguez, Valeria Rios
    Poddubnyy, Denis
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (05) : 493 - 500
  • [42] The role of ixekizumab in non-radiographic axial spondyloarthritis
    San Koo, Bon
    Kim, Tae-Hwan
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [43] Understanding the paradigm of non-radiographic axial spondyloarthritis
    Benavent, Diego
    Navarro-Compan, Victoria
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (02) : 501 - 512
  • [44] Non-radiographic axial spondyloarthritis: a classification or a diagnosis?
    Braun, J.
    Baraliakos, X.
    Kiltz, U.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (01) : S5 - S6
  • [45] Understanding the paradigm of non-radiographic axial spondyloarthritis
    Diego Benavent
    Victoria Navarro-Compán
    [J]. Clinical Rheumatology, 2021, 40 : 501 - 512
  • [46] Sustained Improvements in Workplace and Household Productivity and Social Participation with Certolizumab Pegol over 96 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis.
    van der Heijde, Desiree
    Braun, Juergen
    Rudwaleit, Martin
    Purcaru, Oana
    Kavanaugh, Arthur
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1119 - S1119
  • [47] COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN TURKEY
    Gaglayan, B.
    Firidin, A.
    Yildirim, N.
    Tatar, M.
    Essiz, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A645 - A645
  • [48] The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups
    Kenar, Gokce
    Cetin, Pinar
    Can, Gercek
    Capar, Sedat
    Yarkan, Handan
    Sari, Ismail
    Birlik, Merih
    Onen, Fatos
    Akkoc, Nurullah
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [49] THE BURDEN OF AXIAL SPONDYLOARTHRITIS: A COMPARISON OF THE RADIOGRAPHIC AND NON-RADIOGRAPHIC GROUPS
    Cetin, P.
    Sen, G.
    Capar, S.
    Yarkan, H.
    Kenar, G.
    Sari, I.
    Birlik, M.
    Onen, F.
    Akkoc, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 507 - 507
  • [50] SIMILARITIES AND DIFFERENCES BETWEEN NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
    Poddubnyy, D.
    Inman, R. D.
    Sieper, J.
    Akar, S.
    Munoz-Fernandez, S.
    Hojnik, M.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S110 - S110
12345